Carcinoid Tumor  >>  linsitinib (ASP7487)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
linsitinib (ASP7487) / Sling Therap
NCT01560260: Linsitinib in Treating Patients With Gastrointestinal Stromal Tumors

Checkmark ASCO 2014
May 2014 - May 2014: ASCO 2014
Completed
2
20
US
Laboratory Biomarker Analysis, Linsitinib, IGF-1R inhibitor OSI-906, OSI-906, OSI-906AA, Pharmacological Study
National Cancer Institute (NCI)
Carney Complex, Chondrosarcoma, Gastrointestinal Stromal Tumor, Paraganglioma
10/15
10/15

Download Options